S&P 500   4,296.12 (+0.32%)
DOW   33,717.47 (-0.13%)
QQQ   356.98 (+0.66%)
AAPL   184.49 (+1.96%)
MSFT   337.87 (+0.74%)
META   273.76 (+0.42%)
GOOGL   126.87 (+1.76%)
AMZN   125.10 (+0.68%)
TSLA   218.35 (+2.05%)
NVDA   391.46 (-0.46%)
NIO   7.79 (+3.04%)
BABA   83.85 (-0.50%)
AMD   119.04 (+1.00%)
T   15.37 (+1.05%)
F   12.64 (+2.02%)
MU   68.17 (-1.45%)
CGC   0.79 (-4.40%)
GE   104.63 (-1.11%)
DIS   90.41 (-0.40%)
AMC   4.61 (+1.32%)
PFE   38.81 (+1.17%)
PYPL   64.88 (+1.44%)
NFLX   410.00 (+2.38%)
S&P 500   4,296.12 (+0.32%)
DOW   33,717.47 (-0.13%)
QQQ   356.98 (+0.66%)
AAPL   184.49 (+1.96%)
MSFT   337.87 (+0.74%)
META   273.76 (+0.42%)
GOOGL   126.87 (+1.76%)
AMZN   125.10 (+0.68%)
TSLA   218.35 (+2.05%)
NVDA   391.46 (-0.46%)
NIO   7.79 (+3.04%)
BABA   83.85 (-0.50%)
AMD   119.04 (+1.00%)
T   15.37 (+1.05%)
F   12.64 (+2.02%)
MU   68.17 (-1.45%)
CGC   0.79 (-4.40%)
GE   104.63 (-1.11%)
DIS   90.41 (-0.40%)
AMC   4.61 (+1.32%)
PFE   38.81 (+1.17%)
PYPL   64.88 (+1.44%)
NFLX   410.00 (+2.38%)
S&P 500   4,296.12 (+0.32%)
DOW   33,717.47 (-0.13%)
QQQ   356.98 (+0.66%)
AAPL   184.49 (+1.96%)
MSFT   337.87 (+0.74%)
META   273.76 (+0.42%)
GOOGL   126.87 (+1.76%)
AMZN   125.10 (+0.68%)
TSLA   218.35 (+2.05%)
NVDA   391.46 (-0.46%)
NIO   7.79 (+3.04%)
BABA   83.85 (-0.50%)
AMD   119.04 (+1.00%)
T   15.37 (+1.05%)
F   12.64 (+2.02%)
MU   68.17 (-1.45%)
CGC   0.79 (-4.40%)
GE   104.63 (-1.11%)
DIS   90.41 (-0.40%)
AMC   4.61 (+1.32%)
PFE   38.81 (+1.17%)
PYPL   64.88 (+1.44%)
NFLX   410.00 (+2.38%)
S&P 500   4,296.12 (+0.32%)
DOW   33,717.47 (-0.13%)
QQQ   356.98 (+0.66%)
AAPL   184.49 (+1.96%)
MSFT   337.87 (+0.74%)
META   273.76 (+0.42%)
GOOGL   126.87 (+1.76%)
AMZN   125.10 (+0.68%)
TSLA   218.35 (+2.05%)
NVDA   391.46 (-0.46%)
NIO   7.79 (+3.04%)
BABA   83.85 (-0.50%)
AMD   119.04 (+1.00%)
T   15.37 (+1.05%)
F   12.64 (+2.02%)
MU   68.17 (-1.45%)
CGC   0.79 (-4.40%)
GE   104.63 (-1.11%)
DIS   90.41 (-0.40%)
AMC   4.61 (+1.32%)
PFE   38.81 (+1.17%)
PYPL   64.88 (+1.44%)
NFLX   410.00 (+2.38%)
NASDAQ:GTH

Genetron (GTH) Stock Forecast, Price & News

$0.89
+0.01 (+1.43%)
(As of 12:21 PM ET)
Compare
Today's Range
$0.87
$0.89
50-Day Range
$0.87
$1.06
52-Week Range
$0.73
$1.75
Volume
25,615 shs
Average Volume
61,660 shs
Market Capitalization
$81.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

GTH stock logo

About Genetron (NASDAQ:GTH) Stock

Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. The company has a strategic partnership with JD Health to create solutions for full-cycle cancer management. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the People's Republic of China.

Receive GTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter.

GTH Stock News Headlines

Genetron (NASDAQ:GTH) Trading Down 3.3%
The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
GTH Genetron Holdings Limited
Genetron Holdings Ltd
Genetron Health Announces Receipt of a...
Genetron's Maryland lab gets CAP accreditation
See More Headlines

GTH Price History

GTH Company Calendar

Last Earnings
5/23/2021
Today
6/05/2023
Next Earnings (Estimated)
6/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GTH
Fax
N/A
Employees
1,154
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$650.71 million
Book Value
$0.88 per share

Miscellaneous

Free Float
N/A
Market Cap
$80.64 million
Optionable
Not Optionable
Beta
0.53

Key Executives

  • Mr. Sizhen Wang (Age 46)
    Co-Founder, CEO & Chairman
  • Dr. Wei-Wu He Ph.D. (Age 58)
    Co-Founder & Chairman Emeritus
  • Dr. Hai Yan (Age 55)
    Co-Founder, Chief Scientific Officer & Director
  • Mr. Ce Xu (Age 41)
    Chief Financial Officer
  • Ms. Victoria Lei
    Chief Operating Officer
  • Dr. Yuchen Jiao M.D. (Age 45)
    Ph.D., Chief Technology Officer
  • Mr. Yong Liang (Age 49)
    Chief HR Officer
  • Dr. Yun-Fu Hu Ph.D. (Age 60)
    Chief Medical Officer
  • Ms. Lily Liu
    Chief Commercial Officer













GTH Stock - Frequently Asked Questions

How have GTH shares performed in 2023?

Genetron's stock was trading at $1.12 at the start of the year. Since then, GTH shares have decreased by 21.4% and is now trading at $0.8808.
View the best growth stocks for 2023 here
.

Are investors shorting Genetron?

Genetron saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 158,600 shares, a decline of 8.3% from the April 30th total of 172,900 shares. Based on an average daily volume of 28,200 shares, the days-to-cover ratio is presently 5.6 days. Currently, 0.2% of the company's shares are short sold.
View Genetron's Short Interest
.

When is Genetron's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 6th 2023.
View our GTH earnings forecast
.

How were Genetron's earnings last quarter?

Genetron Holdings Limited (NASDAQ:GTH) posted its quarterly earnings data on Sunday, May, 23rd. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.10. The firm had revenue of $14.05 million for the quarter.
Read the conference call transcript
.

When did Genetron IPO?

(GTH) raised $162 million in an initial public offering on Friday, June 19th 2020. The company issued 13,000,000 shares at a price of $11.50-$13.50 per share. Credit Suisse and CICC acted as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers.

What is Genetron's stock symbol?

Genetron trades on the NASDAQ under the ticker symbol "GTH."

Who are Genetron's major shareholders?

Genetron's stock is owned by a number of retail and institutional investors. Top institutional investors include Hudson Bay Capital Management LP (0.54%), Schonfeld Strategic Advisors LLC (0.17%) and Susquehanna International Group LLP (0.04%).

How do I buy shares of Genetron?

Shares of GTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Genetron's stock price today?

One share of GTH stock can currently be purchased for approximately $0.88.

How much money does Genetron make?

Genetron (NASDAQ:GTH) has a market capitalization of $80.64 million and generates $650.71 million in revenue each year. The company earns $-117,210,000.00 in net income (profit) each year or ($1.18) on an earnings per share basis.

How many employees does Genetron have?

The company employs 1,154 workers across the globe.

How can I contact Genetron?

Genetron's mailing address is 1-2/F BUILDING 11 ZONE 1 CHANGPING DISTRICT, BEIJING F4, 102206. The official website for the company is www.genetronhealth.com. The company can be reached via phone at 86-10-5090-7500 or via email at ir@genetronhealth.com.

This page (NASDAQ:GTH) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -